PharmAla Biotech (CSE:MDMA) has been contracted as a supplier of MDMA to a clinical trial at Harvard’s Maclean HospitalThe largest neuroscientific and psychiatric private research hospital in the world, McLean is ranked 1st among all psychiatric hospitals in the U.S. according to U.S. News & World ReportThe Toronto-based company stated that Researchers can access a new tool, which provides drug product quality information, which researchers can examine directlyPharmAla Biotech Holdings Inc. stock (CSE:MDMA) opened trading at $0.085 per sharePharmAla Biotech (CSE:MDMA) has been contracted as a …